In this study, we found a significant increase in the soluble levels of α1-AT in BC patients compared to HW (Figure 1), and this agrees with the results obtained in the evaluation of soluble levels of α1-AT in patients with other types of cancer, such as those with colorectal cancer [17] and lung cancer [29]. The gene discussed is SERPINA1; the disease is lung carcinoma.